A Study to Evaluate Efficacy and Safety of GW906 in Patients With Essential Hypertension

StatusActive, Not Recruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this study is to evaluate the effect of GW906 on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of GW906.
Trial Details
NCT Number NCT07835971
Lead Sponsor Shenzhen Salubris Pharmaceuticals Co., Ltd.
Conditions
(from sponsor)		 Hypertension
Related terms Hypertension
Enrollment 319 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov